Patents by Inventor Brett Eric Etchebarne

Brett Eric Etchebarne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10570465
    Abstract: This disclosure provides a method for improving the efficiency and timing of detecting whether sepsis-related microorganisms are present in a fluid sample. The method comprises the steps of: collecting the fluid sample from a patient; fractioning the fluid sample to isolate a quantity of microorganism cells; extracting a portion of the microorganism cells from the fluid sample; lysing a portion of the microorganism cells extracted from the fluid sample to extract microorganism DNA; amplifying the microorganism DNA from the microorganism cells from a predetermined set of DNA primers to determine whether sepsis-related microorganisms are present within the fluid sample.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: February 25, 2020
    Inventor: Brett Eric Etchebarne
  • Patent number: 10260111
    Abstract: This disclosure provides a method for improving the efficiency and timing of detecting whether sepsis-related microorganisms are present in a fluid sample. The method comprises the steps of: collecting the fluid sample from a patient; fractioning the fluid sample to isolate a quantity of microorganism cells; extracting a portion of the microorganism cells from the fluid sample; lysing a portion of the microorganism cells extracted from the fluid sample to extract microorganism DNA; amplifying the microorganism DNA from the microorganism cells from a predetermined set of DNA primers to determine whether sepsis-related microorganisms are present within the fluid sample.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: April 16, 2019
    Inventor: Brett Eric Etchebarne
  • Publication number: 20180135108
    Abstract: This disclosure provides a method for detecting bacterial and fungal pathogens at clinically relevant concentrations in a clinical fluid sample using a visual color change test. The method includes the steps of: preparing the clinical fluid sample for heat lysing with water; heat lysing the clinical fluid sample to form a lysate that includes DNA and RNA forming a first mixture; mixing the lysate with a target primer set, EBT dye, a polymerase enzyme, and a chemical reaction buffer in a vial to form a reaction mixture; incubating the reaction mixture; amplifying the optional DNA and RNA and the target primer in the reaction mixture using LAMP; cooling the reaction mixture for a predetermined amount of time stopping the amplification; and identifying a color change in the reaction mixture that is indicative of the presence of bacterial or fungal pathogens.
    Type: Application
    Filed: November 22, 2017
    Publication date: May 17, 2018
    Inventor: Brett Eric Etchebarne